BackDate of JudgmentJuly 8, 2022Issuing AuthorityIntellectual Property High Court of KoreaLevel of the Issuing AuthorityFirst InstanceType of ProcedureJudicial (Administrative)Subject MatterPatents (Inventions)Plaintiff/AppellantCorporation ADefendant/RespondentCorporation C, Corporation E, Corporation HKeywords
Invalidation,
Written pescription requirement,
Pharmaceutical composition,
Invention of pharmaceutical use,
Pharmacological mechanism
Judgment/DecisionEnglishIP High Court Decision, 2021Heo3772, dated July 8, 2022
PDFKorean특허법원 2022.7.8. 선고 2001허3772판결 PDFRelevant Legislation